Fact Based List:
Becker's: 4 Recent Pharmaceutical Purchases Made by U.S.
Submitted by gmccalister on Mon, 11/22/2021 - 11:32
- The U.S. on Oct. 28 purchased 50 million more doses of Pfizer's COVID-19 vaccine to prepare for pediatric vaccinations.
- The U.S. on Nov. 9 purchased 1.4 million more courses of molnupiravir, the COVID-19 antiviral pill Merck is developing with Ridgeback Biotherapeutics, for roughly $1 billion.
- The U.S. said Nov. 16 it will buy 10 million courses of Pfizer's COVID-19 antiviral pill Paxlovid for $5 billion.
- The U.S. on Nov. 17 bought $1 billion worth of COVID-19 monoclonal antibody drug sotrovimab, which is made by GlaxoSmithKline and Vir Biotechnology.
Source: Becker's Hospital Review, November 18, 2021
Source URL: https://www.beckershospitalreview.com/pharmacy/4-recent-phar...
List Ratings: |
Lists You Might Also Be Interested In
- Sydney Rubin: Five Measures to Cope With The Pharmaceutical Side Effects Of Health Reform
- David Lee Scher: Five Ways Pharma Can Benefit From Digital Health Technologies
- Top therapeutic areas (TAs) expected to drive biopharma market growth, 2022-2028
- PCMA: 9 Ways PBMs Improve Clinical Outcomes and Create Sustainable Pharmacy Benefits
- Healthcare Global: 10 Most Innovative Pharma Companies to Watch in 2015
Login or register to post comments